NDC 51655-290

LEVOTHYROXINE

Levothyroxine

LEVOTHYROXINE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals, Llc. The primary component is Levothyroxine Sodium.

Product ID51655-290_64f1daf6-af49-4087-a874-974fed3ecb79
NDC51655-290
Product TypeHuman Prescription Drug
Proprietary NameLEVOTHYROXINE
Generic NameLevothyroxine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-09-14
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA021210
Labeler NameNorthwind Pharmaceuticals, LLC
Substance NameLEVOTHYROXINE SODIUM
Active Ingredient Strength125 ug/1
Pharm Classesl-Thyroxine [EPC],Thyroxine [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 51655-290-52

30 TABLET in 1 BOTTLE, DISPENSING (51655-290-52)
Marketing Start Date2014-09-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51655-290-52 [51655029052]

LEVOTHYROXINE TABLET
Marketing CategoryNDA authorized generic
Application NumberNDA021210
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-09-14
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LEVOTHYROXINE SODIUM125 ug/1

OpenFDA Data

SPL SET ID:bd1ce5e4-9dd5-4bd5-ae5e-c88822c04f98
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 966224
  • Pharmacological Class

    • l-Thyroxine [EPC]
    • Thyroxine [CS]

    NDC Crossover Matching brand name "LEVOTHYROXINE" or generic name "Levothyroxine"

    NDCBrand NameGeneric Name
    43742-0955LevothyroxineLevothyroxine
    51655-091LevothyroxineLevothyroxine
    51655-290LEVOTHYROXINELEVOTHYROXINE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.